We are live on ! Find out more
DRIO icon

DarioHealth

40 hedge funds and large institutions have $6.1M invested in DarioHealth in 2024 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 12 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 2

25% more funds holding

Funds holding: 3240 (+8)

0.32% less ownership

Funds ownership: 1.34%1.02% (-0.32%)

32% less capital invested

Capital invested by funds: $8.98M → $6.1M (-$2.88M)

58% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 12

Holders
40
Holders Change
+8
Holders Change %
+25%
% of All Funds
0.53%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
10
Increased
5
Reduced
12
Closed
2
Calls
$94K
Puts
Net Calls
+$94K
Net Calls Change
-$17K

DRIO Hedge Fund Activity: Q4 2024 in Review

40 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in DarioHealth (DRIO) for Q4 2024, worth a combined $6.1M — down 32% from $8.98M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new DRIO positions and 2 closed out — a net gain of 8 holders — while 5 added to existing stakes and 12 trimmed.

The largest buyer was Lasry Marc, opening a new position worth an estimated $402K. The largest seller was Clal Insurance, cutting an estimated $443K.

  • 40 institutional investors held DarioHealth (DRIO) as of Q4 2024, up from 32 in Q3 2024.
  • Funds reported $6.1M of DarioHealth stock for Q4 2024, down 32% quarter-over-quarter.
  • 10 funds opened new DarioHealth positions in Q4 2024 and 2 closed out, a net change of +8 holders.
  • The largest DarioHealth buyer in Q4 2024 was Lasry Marc, an estimated $402K added.
  • The largest DarioHealth seller in Q4 2024 was Clal Insurance, an estimated $443K sold.

Based on aggregated 13F filings for Q4 2024.